Buy Stocks Easy | About Us

January 28, 2021

MNKD

Buy MannKind Corporation Stock (symbol: MNKD) Easy Online

Company Name: MannKind Corporation

Symbol: MNKD

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2004

MNKD Current Share Price

Today's MNKD ( MannKind Corporation ) opening price: $1.3800

Yesterday's MNKD ( MannKind Corporation ) closing price: $1.3800

MannKind Corporation Stock ( symbol: MNKD ) Price Chart since IPO (2004):

12 Months MannKind Corporation Stock ( symbol: MNKD ) Price Chart

Popular Questions about MannKind Corporation Public Stock ( MNKD )

A: MannKind Corporation stock symbol (also called stock or share ticker) is MNKD

A: MannKind Corporation IPO (Initial Public Offering) took place on 2004

A: MannKind Corporation's stock (MNKD symbol) price at ther IPO (initial Public Offering) was $1.3800

Q: Is MNKD stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'MannKind Corporation stock (symbol: MNKD) at the beginning of 2019, at the opening share price of $1.2600, with a minimum of $200, by now your shares would be worth $31946 and your profit would be $31746 - SHOW ONLY IF PROFIT.

Buy MannKind Corporation Stock Easy Online

MannKind Corporation Stock Ticker Price Chart since IPO:

MannKind Corporation Stock Price Yesterday

MannKind Corporation Stock Price – Last Week

MannKind Corporation Stock Price – Last Month

MannKind Corporation Stock Value Chart – 12 Months

Rate this post

Latest Stock News:

https://www.forbes.com/sites/moneyshow/2020/01/03/7-hot-drug-stocks-to-buy-in-2020/

7 Hot Drug Stocks To Buy In 2020

Each year, MoneyShow asks the nation’s leading financial newsletter...

https://247wallst.com/healthcare-business/2019/12/26/major-biotechs-see-rising-short-interest/

Major Biotechs See Rising Short Interest

The short interest data are out for the most recent settlement date...

http://www.globenewswire.com/news-release/2019/12/20/1963517/0/en/Study-171-Shows-Hypoglycemia-is-Reduced-with-Use-of-Afrezza-Relative-to-Insulin-Aspart-in-Type-1-Diabetes.html

Study 171 Shows Hypoglycemia is Reduced with Use of Afrezza® Relative to Insulin Aspart in Type 1 Diabetes

Publication in DIABETICMedicine Now Available Online Publication in...

https://seekingalpha.com/article/4303332-mannkind-corporation-mnkd-ceo-michael-castagna-q3-2019-results-earnings-call-transcript

MannKind Corporation (MNKD) CEO Michael Castagna on Q3 2019 Results - Earnings Call Transcript

MannKind Corporation (MNKD) CEO Michael Castagna on Q3 2019 Results...

http://www.globenewswire.com/news-release/2019/10/30/1937980/0/en/MannKind-Corporation-to-Hold-2019-Third-Quarter-Financial-Results-Conference-Call-on-November-6-2019.html

MannKind Corporation to Hold 2019 Third Quarter Financial Results Conference Call on November 6, 2019

WESTLAKE VILLAGE, Calif., Oct. 30, 2019 (GLOBE NEWSWIRE) -- MannK...

https://247wallst.com/healthcare-business/2019/10/25/major-biotechs-see-rising-tide-in-short-interest-4/

Major Biotechs See Rising Tide in Short Interest (Oct 25)

The short interest data are out for the most recent settlement date...

http://www.globenewswire.com/news-release/2019/09/26/1921275/0/en/MannKind-Corporation-to-Present-at-the-2019-Cantor-Global-Healthcare-Conference.html

MannKind Corporation to Present at the 2019 Cantor Global Healthcare Conference

WESTLAKE VILLAGE, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Mann...

https://seekingalpha.com/article/4292926-mannkind-afrezza-scripts-flat-positive-events-deck

MannKind: Afrezza Scripts Flat, But Positive Events On Deck

Afrezza scripts came in at just over 700 for the week.

http://www.globenewswire.com/news-release/2019/09/19/1917999/0/en/MannKind-Presents-Positive-Afrezza-Clinical-Data-from-Type-1-Diabetes-Study-at-55th-Annual-Meeting-of-the-EASD.html

MannKind Presents Positive Afrezza® Clinical Data from Type 1 Diabetes Study at 55th Annual Meeting of the EASD

WESTLAKE VILLAGE, Calif., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Mann...

https://247wallst.com/healthcare-business/2019/09/12/major-biotechs-scare-off-short-sellers-3/

Major Biotechs Scare Off Short Sellers

The short interest data are out for the most recent settlement date...

All right reserved Buy Stocks Easy , 2019.